{
  "image_filename": "table_p5_det_4_007.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_007.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_007",
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "supports_claim": false,
  "explanation": "A table comparing demographic and clinical characteristics of adults aged 18\u201364 and \u226565 years by vaccine received (recombinant quadrivalent influenza vaccine [RIV4] versus standard-dose egg-based quadrivalent influenza vaccine [SD-IIV4], and in \u226565 also high-dose and adjuvanted egg-based vaccines). Variables include race, sex, season, influenza cases, and high-risk conditions with counts, percentages, and P-values. does not support the claim because the table only presents demographic and case-status comparisons, not any measures of antibody response or immunogenicity.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table comparing demographic and clinical characteristics of adults aged 18\u201364 and \u226565 years by vaccine received (recombinant quadrivalent influenza vaccine [RIV4] versus standard-dose egg-based quadrivalent influenza vaccine [SD-IIV4], and in \u226565 also high-dose and adjuvanted egg-based vaccines). Variables include race, sex, season, influenza cases, and high-risk conditions with counts, percentages, and P-values.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only presents demographic and case-status comparisons, not any measures of antibody response or immunogenicity.",
    "confidence_notes": null
  }
}